Home
ARVN
ARVN News

Latest Arvinas Inc. (ARVN) News on July 27, 2024

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

GlobeNewswire

5 days ago

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

Biotech Arvinas Stock Earns 82 RS Rating

Investor's Business Daily

9 days ago

Biotech Arvinas Stock Earns 82 RS Rating

Arvinas (ARVN) Surges 9.2%: Is This an Indication of Further Gains?

Zacks

10 days ago

Arvinas (ARVN) Surges 9.2%: Is This an Indication of Further Gains?

Milestone Pharmaceuticals Refreshes Board of Directors

GlobeNewswire

12 days ago

Milestone Pharmaceuticals Refreshes Board of Directors

Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy Rating?

Insider Monkey

a month ago

Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy Rating?

MT Newswires

a month ago

Arvinas Names Andrew Saik as Chief Financial Officer; Shares Rise After Hours

Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer

GlobeNewswire

a month ago

Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer

Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?

Zacks

a month ago

Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?

Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2

GlobeNewswire

a month ago

Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2

Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer

GlobeNewswire

a month ago

Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

2 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CNW Group

2 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

2 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

2 months ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

2 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

2 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

2 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Arvinas to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

Arvinas to Participate in Upcoming Investor Conferences

Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress

GlobeNewswire

2 months ago

Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress

It Looks Like Arvinas, Inc.'s (NASDAQ:ARVN) CEO May Expect Their Salary To Be Put Under The Microscope

Simply Wall St.

2 months ago

It Looks Like Arvinas, Inc.'s (NASDAQ:ARVN) CEO May Expect Their Salary To Be Put Under The Microscope

MT Newswires

2 months ago

Sector Update: Health Care Stocks Steady Premarket Thursday

MT Newswires

2 months ago

Correction: Arvinas, Pfizer Breast Cancer Treatment Shows 'Encouraging' Clinical Activity

MT Newswires

2 months ago

Arvinas, Pfizer Breast Cancer Treatment Shows 'Encouraging' Clinical Activity

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)

GlobeNewswire

2 months ago

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)

Arvinas, Inc. (NASDAQ:ARVN) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Simply Wall St.

3 months ago

Arvinas, Inc. (NASDAQ:ARVN) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

GlobeNewswire

3 months ago

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

MT Newswires

3 months ago

Oppenheimer Adjusts Arvinas Price Target to $70 From $80, Maintains Outperform Rating

We Think Arvinas (NASDAQ:ARVN) Can Afford To Drive Business Growth

Simply Wall St.

3 months ago

We Think Arvinas (NASDAQ:ARVN) Can Afford To Drive Business Growth

MT Newswires

3 months ago

Arvinas Shares Up After Q1 Net Loss Narrows

Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates

Zacks

3 months ago

Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates

Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

3 months ago

Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update

Why Earnings Season Could Be Great for Arvinas (ARVN)

Zacks

3 months ago

Why Earnings Season Could Be Great for Arvinas (ARVN)

Arvinas to Present at Upcoming Investor Conferences

GlobeNewswire

3 months ago

Arvinas to Present at Upcoming Investor Conferences

Arvinas (ARVN) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

3 months ago

Arvinas (ARVN) Upgraded to Buy: What Does It Mean for the Stock?

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline

Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

3 months ago

Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer

GlobeNewswire

3 months ago

Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Zacks

3 months ago

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Associated Press Finance

3 months ago

Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Investor's Business Daily

3 months ago

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Reuters

4 months ago

UPDATE 2-Novartis taps Arvinas' cancer drug for up to $1 billion

Reuters

4 months ago

Novartis licenses Arvinas' cancer drug for up to $1 billion

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer

GlobeNewswire

4 months ago

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer

Is Arvinas (ARVN) Stock a Solid Choice Right Now?

Zacks

4 months ago

Is Arvinas (ARVN) Stock a Solid Choice Right Now?

Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

GlobeNewswire

4 months ago

Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Arvinas to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

Arvinas to Participate in Upcoming Investor Conferences

Arvinas, Inc. (NASDAQ:ARVN) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall St.

5 months ago

Arvinas, Inc. (NASDAQ:ARVN) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Is a Surprise Coming for Arvinas (ARVN) This Earnings Season?

Zacks

5 months ago

Is a Surprise Coming for Arvinas (ARVN) This Earnings Season?

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates

Zacks

5 months ago

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates

Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Arvinas (NASDAQ:ARVN) shareholders are still up 143% over 5 years despite pulling back 10% in the past week

Simply Wall St.

5 months ago

Arvinas (NASDAQ:ARVN) shareholders are still up 143% over 5 years despite pulling back 10% in the past week

Wall Street Analysts See a 30.21% Upside in Arvinas, Inc. (ARVN): Can the Stock Really Move This High?

Zacks

5 months ago

Wall Street Analysts See a 30.21% Upside in Arvinas, Inc. (ARVN): Can the Stock Really Move This High?

What Makes Arvinas, Inc. (ARVN) a Strong Momentum Stock: Buy Now?

Zacks

5 months ago

What Makes Arvinas, Inc. (ARVN) a Strong Momentum Stock: Buy Now?

Arvinas Announces Chief Financial Officer Transition

GlobeNewswire

5 months ago

Arvinas Announces Chief Financial Officer Transition

Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC® Protein Degrader for Neurodegenerative Disease

GlobeNewswire

5 months ago

Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC® Protein Degrader for Neurodegenerative Disease

Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer

GlobeNewswire

5 months ago

Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer

Goldman Sachs Predicts at Least 45% Rally for These 2 ‘Strong Buy’ Stocks — Here’s Why They Have Solid Upside

TipRanks

6 months ago

Goldman Sachs Predicts at Least 45% Rally for These 2 ‘Strong Buy’ Stocks — Here’s Why They Have Solid Upside

Wall Street Analysts Think Arvinas, Inc. (ARVN) Could Surge 26.67%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think Arvinas, Inc. (ARVN) Could Surge 26.67%: Read This Before Placing a Bet

Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer

GlobeNewswire

6 months ago

Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer

Philips' (PHG) New Innovation to Enhance Cardiovascular Imaging

Zacks

6 months ago

Philips' (PHG) New Innovation to Enhance Cardiovascular Imaging

Arvinas, Inc. (ARVN) Soars 10.0%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Arvinas, Inc. (ARVN) Soars 10.0%: Is Further Upside Left in the Stock?

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Sirius XM Holdings Inc Earnings Call

Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference

GlobeNewswire

6 months ago

Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference

McGrath Sets Fourth Quarter 2023 Financial Results Date and Time

Business Wire

6 months ago

McGrath Sets Fourth Quarter 2023 Financial Results Date and Time

Sirius XM (SIRI) Q4 2023 Earnings Call Transcript

Motley Fool

6 months ago

Sirius XM (SIRI) Q4 2023 Earnings Call Transcript

Want $1,000 in Super-Safe Dividend Income in 2024? Invest $9,750 Into the Following 3 Ultra-High-Yield Stocks

Motley Fool

6 months ago

Want $1,000 in Super-Safe Dividend Income in 2024? Invest $9,750 Into the Following 3 Ultra-High-Yield Stocks

Adtalem (ATGE) Q2 Earnings & Revenues Top, '24 View Raised

Zacks

6 months ago

Adtalem (ATGE) Q2 Earnings & Revenues Top, '24 View Raised

Starbucks slashes sales guidance after missing the mark in Q1 earnings

Yahoo Finance

6 months ago

Starbucks slashes sales guidance after missing the mark in Q1 earnings

Short Seller Who Targeted Valeant Aims at Education Firm Adtalem

Bloomberg

6 months ago

Short Seller Who Targeted Valeant Aims at Education Firm Adtalem

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

GlobeNewswire

6 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

GlobeNewswire

6 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Should Value Investors Buy Fulton Financial (FULT) Stock?

Zacks

6 months ago

Should Value Investors Buy Fulton Financial (FULT) Stock?

Leidos to Participate in the TD Cowen 45th Annual Aerospace & Defense Conference

PR Newswire

6 months ago

Leidos to Participate in the TD Cowen 45th Annual Aerospace & Defense Conference

Corcept Appoints Roberto Vieira as President, Oncology

GlobeNewswire

6 months ago

Corcept Appoints Roberto Vieira as President, Oncology

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 01/29/2024

Girona take Liga lead back with win at Celta

AFP

6 months ago

Girona take Liga lead back with win at Celta

2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street

Motley Fool

6 months ago

2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street

Institutional investors are Opendoor Technologies Inc.'s (NASDAQ:OPEN) biggest bettors and were rewarded after last week's US$134m market cap gain

Simply Wall St.

6 months ago

Institutional investors are Opendoor Technologies Inc.'s (NASDAQ:OPEN) biggest bettors and were rewarded after last week's US$134m market cap gain

3M's Financials Are Improving. Is That Enough to Save This Dow Stock's 6%-Yielding Dividend?

Motley Fool

6 months ago

3M's Financials Are Improving. Is That Enough to Save This Dow Stock's 6%-Yielding Dividend?

New Strong Buy Stocks for January 26th

Zacks

6 months ago

New Strong Buy Stocks for January 26th

WSFS Financial (WSFS) Q4 Earnings and Revenues Top Estimates

Zacks

6 months ago

WSFS Financial (WSFS) Q4 Earnings and Revenues Top Estimates

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks

6 months ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Associated Press Finance

6 months ago

Liberty Oilfield Services: Q4 Earnings Snapshot

Liberty Energy Inc. Announces Fourth Quarter and Full Year 2023 Financial and Operational Results and Increase in Existing Share Repurchase Authorization to $750 Million

Business Wire

6 months ago

Liberty Energy Inc. Announces Fourth Quarter and Full Year 2023 Financial and Operational Results and Increase in Existing Share Repurchase Authorization to $750 Million

Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2024 Third Quarter Earnings Release and Conference Call Webcast

GlobeNewswire

6 months ago

Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2024 Third Quarter Earnings Release and Conference Call Webcast

Varonis Extends Data Security Posture Management Coverage to Snowflake

GlobeNewswire

6 months ago

Varonis Extends Data Security Posture Management Coverage to Snowflake

Marriott Vacations Worldwide Corporation Announces Fourth Quarter Earnings Release and Conference Call

Business Wire

6 months ago

Marriott Vacations Worldwide Corporation Announces Fourth Quarter Earnings Release and Conference Call

Strength Seen in Tronox (TROX): Can Its 7.6% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in Tronox (TROX): Can Its 7.6% Jump Turn into More Strength?

Arbor Realty Trust (ABR) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

6 months ago

Arbor Realty Trust (ABR) Stock Falls Amid Market Uptick: What Investors Need to Know

GuruFocus.com

6 months ago

Park National Corp (PRK) Reports Decline in 2023 Earnings Amid Economic Challenges

Associated Press Finance

6 months ago

Park National: Q4 Earnings Snapshot

Park National Corporation reports 2023 financial results

GlobeNewswire

6 months ago

Park National Corporation reports 2023 financial results

Investment Opportunities in the Innovation Economy Headline the 2024 Emerald Groundhog Day Investment Forum

Business Wire

6 months ago

Investment Opportunities in the Innovation Economy Headline the 2024 Emerald Groundhog Day Investment Forum

Return Trends At Albany International (NYSE:AIN) Aren't Appealing

Simply Wall St.

6 months ago

Return Trends At Albany International (NYSE:AIN) Aren't Appealing

Yelp Inc CFO David Schwarzbach Sells 2,750 Shares

GuruFocus.com

6 months ago

Yelp Inc CFO David Schwarzbach Sells 2,750 Shares

Business Wire

6 months ago

Cirrus Logic to Report Third Quarter Fiscal Year 2024 Results

Investing.com

6 months ago

Wells Fargo downgraded after Q4 earnings, Adobe slashed: 4 big analyst cuts

What Makes Arvinas, Inc. (ARVN) a New Strong Buy Stock

Zacks

6 months ago

What Makes Arvinas, Inc. (ARVN) a New Strong Buy Stock

Arvinas Appoints Jared Freedberg as General Counsel

GlobeNewswire

6 months ago

Arvinas Appoints Jared Freedberg as General Counsel

Share on Social Networks: